ScholarIQanswers from OpenAlex
Intarcia Therapeutics
FunderResearch funding and supported work
Intarcia Therapeutics is a funder indexed in ScholarIQ from OpenAlex.
What is known about Intarcia Therapeutics?
ScholarIQrecord summary
American pharmaceutical company
How many works does Intarcia Therapeutics have?
ScholarIQindexed works
Intarcia Therapeutics has 399 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Intarcia Therapeutics?
ScholarIQopenalex
The OpenAlex for Intarcia Therapeutics is on the source record.
What is the ROR of Intarcia Therapeutics?
ScholarIQror
The ROR for Intarcia Therapeutics is on the source record.
What are the most-cited papers on Intarcia Therapeutics?
ScholarIQmost cited works
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity
Domenica Rubino, Domenica Rubino, Niclas Abrahamsson, Melanie Davies, Dan Hesse, Frank L. Greenway, Camilla Jensen, Ildiko Lingvay, Ofri Mosenzon, Julio Rosenstock, Miguel A. Rubio, Gottfried Rudofsky, Sayeh Tadayon, Thomas A. Wadden, Dror Dicker, STEP 4 Investigators, M. Friberg, Anders Sjödin, Dror Dicker, Gabriella Segal, Ofri Mosenzon, Muhammad Sabbah, Yael Sofer, Victor Vishlitzky, Eelco W. Meesters, Mirelle Serlie, Arianne van Bon, Helena Cardoso, Paula Freitas, Pedro Carneiro de Melo, Mariana P. Monteiro, Mariana Monteiro, Dírcea Rodrigues, Aysha Badat, P Joshi, Gulam Latiff, Essack A. Mitha, Hans H. Snyman, Elane van Nieuwenhuizen, Olga González Albarrán, Assumpta Caixàs, Carmen de al Cuesta, Pedro Pablo Garcia Luna, Cristobal Morales Portillo, Pedro Mezquita Raya, Miguel Angel Rubio, Niclas Abrahamsson, Johan Hoffstedt, Fredrik von Wowern, Erik Uddman, Birgit Bach-Kliegel, Felix Beuschlein, Stefan Bilz, Alain Golay, Gottfried Rudofsky, Christopher Strey, Н. В. Косей, Т. Ф Татарчук, Тетяна Татарчук, Valentyna Velychko, Olesya Zinych, Stephen Aronoff, Harold E. Bays, Andrew P. Brockmyre, Robert S. Call, Charles Crump, Cyrus V. Desouza, Valerie Espinosa, Almena Free, Winston H. Gandy, Steven A. Geller, Gregory Gottschlich, Frank L. Greenway, Laurie Han-Conrad, Wayne Harper, L A Herman, Mitzie Hewitt, Ph. Hollander, Steven R. Kaster, Anastasios Manessis, Frederick A. Martin, Robert E. McNeill, Alexander V. Murray, Paul Norwood, John C.H. Reed, Julio Rosenstock, Domenica M. Rubino, Domenica M. Rubino, Martin Schear, Mark Warren
Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction
Pardeep S. Jhund, Scott D. Solomon, Kieran F. Docherty, Hiddo J.L. Heerspink, Inder S. Anand, Michael Böhm, Vijay Chopra, Rudolf A. de Boer, Akshay S. Desai, Junbo Ge, Masafumi Kitakaze, Bela Merkley, Eileen O’Meara, Morten Shou, С. Н. Терещенко, Subodh Verma, Pham Nguyễn Vinh, Silvio E. Inzucchi, Lars Køber, Mikhail Kosiborod, Felipe A. Martínez, Piotr Ponikowski, Marc S. Sabatine, Olof Bengtsson, Anna Maria Langkilde, Mikaela Sjöstrand, John J.V. McMurray
Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial
Helen M. Colhoun, Ildiko Lingvay, Paul Brown, John Deanfield, Kirstine Brown‐Frandsen, Steven E. Kahn, Jorge Plutzky, Koichi Node, Alexander Parkhomenko, Lars Rydén, John Wilding, Johannes F.E. Mann, Katherine R. Tuttle, Thomas Idorn, Naveen Rathor, A. Michael Lincoff
Initial Decline (Dip) in Estimated Glomerular Filtration Rate After Initiation of Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: Insights From DAPA-HF
Carly Adamson, Kieran F. Docherty, Hiddo J.L. Heerspink, Rudolf A. de Boer, Kevin Damman, Silvio E. Inzucchi, Lars Køber, Mikhail Kosiborod, Felipe A. Martínez, Mark C. Petrie, Piotr Ponikowski, Marc S. Sabatine, Morten Schou, Scott D. Solomon, Subodh Verma, Olof Bengtsson, Anna Maria Langkilde, Mikaela Sjöstrand, Muthiah Vaduganathan, Pardeep S. Jhund, John J.V. McMurray